Back to search results

Voice Analysis for Monitoring Heart Failure

This study is looking at how changes in your voice might help doctors monitor heart failure. Researchers will collect daily voice recordings from people with acutely decompensated heart failure (ADHF), which is when heart failure symptoms suddenly get worse, during their hospital stay. They will compare these voice changes with other medical information, like heart function and blood test results. The goal is to find voice patterns that could show how heart failure is progressing, potentially leading to new ways to track your health from home. This study is for adults aged 18 and older who have been diagnosed with ADHF. It is currently unclear if the study is actively recruiting.

Study design
This is an observational study involving about 70 participants. It is not testing a specific treatment, but rather observing changes in voice.
What's involved
You would provide daily voice recordings during your hospital stay, from when you are admitted until you are discharged.
Compensation
Not stated in the trial record.
Follow-up
Your voice characteristics will be measured during your hospital stay, from admission to discharge.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06566911

Voice Analysis for Monitoring Patients With Heart Failure

UNKNOWN
Not specifiedAges 18+Observational
Noah Labs
~70 participants
Updated 2024-08-22 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in vocal characteristics from admission to discharge and their correlation with heart failure severity markers.
Measured over Hospital stay

Conditions

Heart Failure

Explore related trials

Heart Failure

NCT06566911

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Mayo Clinic

    Rochester, Minnesotano site contact published

    Recruiting

  • Deutsches Herzzentrum der Charité

    Berlin, Germanyno site contact published

    Completed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Gerhard Hindricks, MD · PRINCIPAL_INVESTIGATOR · German Heart Institute

Who to contact

Leonhard Riehle, MD
[email protected]
+49 32 221093495
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Clinically diagnosed with Acutely Decompensated Heart Failure.
At least 18 years of age.

Exclusion

Disabling mental diseases (e.g., Alzheimer's disease)
Clinically diagnosed chronic obstructive pulmonary disease (COPD)
Treatment in ICU or IMU
Dialysis treatment
Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
Neurodegenerative diseases
Pregnancy
Inability to provide consent

What this trial measures

  • Change in vocal characteristics from admission to discharge and their correlation with heart failure severity markers.Hospital stay

    The primary endpoint is the change in vocal characteristics from admission to discharge, and its correlation with clinical markers of heart failure severity, such as weight change from admission to discharge, NTpro-BNP levels, ECG-parameters, and left ventricular ejection fraction (LVEF).